Accu-Chek SmartGuide CGM solution
Help your patients to manage their diabetes better¹ with the Accu-Chek SmartGuide CGM solution. Its predictive features may help them act before hyperglycemia or hypoglycemia happens.¹
Help your patients to manage their diabetes better¹ with the Accu-Chek SmartGuide CGM solution
-
Real-time glucose readings
- Our easy-to-use CGM solution provides accurate2 rt-CGM readings without daily finger-pricking3 — so your patients always know their glucose levels and whether they need attention.
-
Improving glycemic control
- Our CGM solution shows your patients when their glucose needs attention, which could help them to improve their glycemic control and time in range.1
-
Reducing the risk of glucose excursions
- By predicting your patients’ upcoming glucose values, our CGM solution may help them act or prepare to reduce the risk of hyper- or hypoglycemia.1
Smart predictions could reduce the risk of excursions¹
The predictions could help patients to reduce the risk of hyper- and hypoglycemia<sup>1</sup> by providing timely warnings when their glucose levels need attention.<br><div class="col-12 p-0 d-md-flex justify-content-center" style="margin-top: 60px;"> <div class="mysugr-cta-button d-flex gap-4 mb-4 justify-content-center"><img style="max-height:60px;" src="/sites/g/files/papvje431/files/2026-06/Buttons.png"></div> </div>
Low Glucose Predict
30 minutes prediction
The Low Glucose Predict feature alerts your patients when hypoglycemia is likely to happen within 30 minutes, so they can act immediately to reduce its risk, or reduce its duration and severity.
What is included in our CGM solution?
-
Accu-Chek SmartGuide sensor
- A comfortable and water-resistant sensor your patients can wear for up to two weeks to provide accurate2, real-time glucose readings without finger-pricking multiple times a day.3 Applying the sensor is quick and easy with our all-in-one applicator.
-
mySugr app
- The mySugr app helps patients to monitor their glucose and keep track of insulin injections, carbohydrate intake, and personal activities. The app estimates where your patients’ glucose will go in the next 30 minutes, 2 hours, and during the night, so they can act or prepare to reduce the risk of hyper- or hypoglycemia.1 Seeing their CGM data supports patients to learn how their lifestyle and therapy influence their glucose levels.5,6
Proven Accu-Chek SmartGuide CGM sensor accuracy
Accuracy of data
Proven accuracy with a MARD of 9.2%2 — so your patients have reliable information about their glucose levels.7
Insulin Dosing
The CGM solution offers easy access to accurate3 real-time glucose data, which your patients can use to dose their insulin with confidence.7
All the collected CGM data you need in one place.
Accu-Chek Care provides all the collected data from your patients' CGM solution, so you can deliver personalized care.8
- Access CGM data transferred automatically (once connected, patient consent is required).
- View structured visualizations and reports using the latest AGP standards.
- Identify glucose patterns and trends.
This helps you spend less time gathering and structuring data, so you can focus on understanding your patients and responding to their needs.
CGM Learning Center
Bite-sized content helps patients learn everything they need to know, and our customer care team is available to answer any questions.
- Guided product training
- Educational articles and videos
- Quick answers to questions

-
Guided product training
-
Educational articles and videos
-
Quick answers to questions
Speak to an Accu-Chek representative
<div class="clearfix text-formatted field field--name-field-hero-text-image-bodysugar field--type-text field--label-hidden field__item"><p>We’re here to help! Get in touch with Accu-Chek Customer Care.</p> </div>
Contact our Customer Support Centre to confirm smartphone compatibility with the mySugr app.
Accu-Chek SmartGuide is currently only available in South Africa.
The Accu-Chek SmartGuide CGM solution is intended for adults with diabetes aged 18+.
- Simulation study, study data not published yet, data on file, Roche Diabetes Care GmbH, 2025.
- Mader JK, Waldenmaier D, Mueller-Hoffmann W, et al. Performance of a Novel Continuous Glucose Monitoring Device in People With Diabetes. J Diabetes Sci Technol. 2024 Sep;18(5):1044-1051.
- Calibration as requested by the mySugr app is required. In certain situations, your patients should use a blood glucose meter to make self-management decisions: for example, if their glucose value doesn’t match how they feel or for any therapy-related decisions while their Accu-Chek SmartGuide sensor is in Trend Mode (as well as in any other case indicated by the user’s manual or their healthcare professional).
- Glatzer T, Ringemann C, Militz D, Mueller-Hoffman W. Concept and Implementation of a Novel Continuous Glucose Predictions on Board. J Diabetes Sci Technol. 2024;18(5):1004-1008.
- Rivera-Ávila DA, Esquivel-Lu AI, Salazar-Lozano CR, Jones K, Doubova SV. The effects of professional continuous glucose monitoring as an adjuvant educational tool for improving glycemic control in patients with type 2 diabetes. BMC Endocr Disord. 2021 Apr 23;21(1):79.
- Carlson AL, Mullen DM, Bergenstal RM. Clinical Use of Continuous Glucose Monitoring in Adults with Type 2 Diabetes. Diabetes Technol Ther. 2017 May;19(S2):S4-S11.
- The mySugr app predicts the general estimated glucose development within the next 2 hours (Glucose Predict) , the estimated high risk of low glucose within the next 30 minutes (Low Glucose Predict) , and the estimated risk of a night-time hypo for the upcoming 7 hours (Night Low Predict, active between 21:00 and 02:00).
- Calibration as requested by the mySugr app is required.
- Orive Milla N, Radiceska D, Koenig H. Clinical benefit of a diabetes management solution for HCPs: a cross-sectional analysis across ES, UK, US and BR. EASD Oct 2023. Abstract #870.